Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) Director Wayne A.I. Frederick sold 3,000 shares of the company's stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $45.54, for a total value of $136,620.00. Following the completion of the sale, the director now owns 26,514 shares of the company's stock, valued at approximately $1,207,447.56. The trade was a 10.16 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Tempus AI Price Performance
TEM traded down $3.63 during trading hours on Friday, hitting $42.54. The company's stock had a trading volume of 11,236,306 shares, compared to its average volume of 5,328,798. The business's 50-day moving average price is $58.45 and its 200-day moving average price is $51.51. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45.
Institutional Trading of Tempus AI
Large investors have recently made changes to their positions in the business. GF Fund Management CO. LTD. bought a new position in shares of Tempus AI in the 4th quarter valued at about $108,000. Voloridge Investment Management LLC bought a new stake in shares of Tempus AI in the 4th quarter valued at approximately $11,826,000. Two Sigma Advisers LP purchased a new position in shares of Tempus AI in the 4th quarter worth approximately $625,000. ProShare Advisors LLC bought a new position in shares of Tempus AI during the 4th quarter valued at approximately $244,000. Finally, Lazard Asset Management LLC purchased a new stake in Tempus AI during the 4th quarter valued at $1,034,000. 24.22% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of research firms have weighed in on TEM. Bank of America upped their price target on shares of Tempus AI from $54.00 to $60.00 and gave the stock a "neutral" rating in a research report on Monday, March 3rd. Piper Sandler cut their price target on Tempus AI from $70.00 to $55.00 and set a "neutral" rating for the company in a research note on Tuesday, March 4th. JPMorgan Chase & Co. cut Tempus AI from an "overweight" rating to a "neutral" rating and raised their price target for the company from $50.00 to $55.00 in a report on Tuesday, February 25th. Wolfe Research lowered Tempus AI from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Finally, William Blair reissued a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Six investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $61.18.
View Our Latest Analysis on Tempus AI
About Tempus AI
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Articles
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
